Li–Fu Hu

1.5k total citations
33 papers, 1.2k citations indexed

About

Li–Fu Hu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Li–Fu Hu has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Li–Fu Hu's work include Viral-associated cancers and disorders (15 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related gene regulation (7 papers). Li–Fu Hu is often cited by papers focused on Viral-associated cancers and disorders (15 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related gene regulation (7 papers). Li–Fu Hu collaborates with scholars based in Sweden, China and Vietnam. Li–Fu Hu's co-authors include Ingemar Ernberg, Ingemar Ernberg, George Klein, Gösta Winberg, Chen Fu, Jian‐Yong Shao, Xi Zheng, Fu Chen, Guangwu Huang and Yi‐Xin Zeng and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer.

In The Last Decade

Li–Fu Hu

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li–Fu Hu Sweden 21 774 425 329 242 185 33 1.2k
Toshiyuki Horikawa Japan 12 678 0.9× 326 0.8× 194 0.6× 240 1.0× 145 0.8× 13 929
Qiuliang Wu China 16 446 0.6× 407 1.0× 96 0.3× 275 1.1× 45 0.2× 37 922
Nobuyuki Bandoh Japan 18 504 0.7× 234 0.6× 172 0.5× 176 0.7× 38 0.2× 63 1.0k
Shuhei Sakakibara Japan 20 827 1.1× 331 0.8× 172 0.5× 84 0.3× 163 0.9× 45 1.3k
R.H. Hruban United States 13 966 1.2× 684 1.6× 391 1.2× 570 2.4× 23 0.1× 24 1.7k
Brian Cao United States 17 381 0.5× 638 1.5× 96 0.3× 174 0.7× 42 0.2× 37 1.2k
Boris Kubuschok Germany 21 511 0.7× 472 1.1× 146 0.4× 121 0.5× 27 0.1× 49 1.5k
Adel K. El‐Naggar United States 12 302 0.4× 337 0.8× 111 0.3× 200 0.8× 40 0.2× 15 815
Stephen M. Thirdborough United Kingdom 21 494 0.6× 452 1.1× 88 0.3× 261 1.1× 13 0.1× 31 1.3k
Andre L. Reed United States 8 505 0.7× 613 1.4× 97 0.3× 186 0.8× 43 0.2× 11 1.0k

Countries citing papers authored by Li–Fu Hu

Since Specialization
Citations

This map shows the geographic impact of Li–Fu Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li–Fu Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li–Fu Hu more than expected).

Fields of papers citing papers by Li–Fu Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li–Fu Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li–Fu Hu. The network helps show where Li–Fu Hu may publish in the future.

Co-authorship network of co-authors of Li–Fu Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Li–Fu Hu. A scholar is included among the top collaborators of Li–Fu Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li–Fu Hu. Li–Fu Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xin, et al.. (2025). A novel TGFBR2 mutation causes Loeys-Dietz syndrome in a Chinese infant: A case report. Heliyon. 11(2). e42116–e42116.
2.
Chen, Xin, et al.. (2019). COX7A1 suppresses the viability of human non‐small cell lung cancer cells via regulating autophagy. Cancer Medicine. 8(18). 7762–7773. 20 indexed citations
3.
Liu, Pengfei, Yetong Feng, Xin Chen, et al.. (2019). Paracrine action of human placental trophoblast cells attenuates cisplatin-induced acute kidney injury. Life Sciences. 230. 45–54. 5 indexed citations
4.
Cui, Qian, Wensheng Liu, Yun-Miao Guo, et al.. (2015). A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma. Chinese Journal of Cancer. 34(3). 563–72. 29 indexed citations
5.
Qiu, Xiaoming, Heng Wu, Li Yang, et al.. (2014). Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer. Epigenetics. 9(8). 1138–1148. 25 indexed citations
6.
Zhang, Zhe, Di Sun, Susanna Hilda Hutajulu, et al.. (2012). Development of a Non-Invasive Method, Multiplex Methylation Specific PCR (MMSP), for Early Diagnosis of Nasopharyngeal Carcinoma. PLoS ONE. 7(11). e45908–e45908. 25 indexed citations
7.
Hu, Li–Fu, Qianhui Qiu, Di Sun, et al.. (2008). A genome-wide scan suggests a susceptibility locus on 5p13 for nasopharyngeal carcinoma. European Journal of Human Genetics. 16(3). 343–349. 28 indexed citations
8.
Hu, Li–Fu, et al.. (2008). Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. Virus Genes. 37(2). 273–281. 23 indexed citations
9.
Hu, Li–Fu, et al.. (2007). Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-κB signaling pathways. Biochemical and Biophysical Research Communications. 360(1). 263–268. 13 indexed citations
10.
Ernberg, Ingemar, et al.. (2007). A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Research. 132(1-2). 15–24. 26 indexed citations
11.
Zhang, Zhe, et al.. (2006). Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. International Journal of Cancer. 120(1). 32–38. 70 indexed citations
12.
Sun, Di, et al.. (2006). Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncology. 43(1). 82–87. 50 indexed citations
13.
Cao, Yun, Xiaoping Miao, Ma-Yan Huang, et al.. (2006). Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer. 6(1). 167–167. 52 indexed citations
14.
Zhang, Xiangning, et al.. (2004). Epstein‐Barr virus‐encoded latent membrane protein 1 promotes stress‐induced apoptosis upstream of caspase‐2‐dependent mitochondrial perturbation. International Journal of Cancer. 113(3). 397–405. 20 indexed citations
15.
Zhang, Xiao-Shi, Li–Fu Hu, Ang Li, et al.. (2004). V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Letters. 211(1). 11–18. 48 indexed citations
16.
Shao, Jian‐Yong, Yuhong Li, Qiuliang Wu, et al.. (2004). Comparison of plasma Epstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer. 100(6). 1162–1170. 172 indexed citations
17.
Zhang, Xiangning, Li–Fu Hu, Bengt Fadeel, & Ingemar Ernberg. (2002). Apoptosis Modulation of Epstein–Barr Virus-Encoded Latent Membrane Protein 1 in the Epithelial Cell Line HeLa Is Stimulus-Dependent. Virology. 304(2). 330–341. 20 indexed citations
18.
Hu, Li–Fu, Guðný Eiríksdóttir, Andrei Alimov, et al.. (1996). Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes and Cancer. 17(2). 118–126. 44 indexed citations
19.
Zheng, Xi, Li–Fu Hu, Fu Chen, & Birger Christensson. (1994). Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. European Journal of Cancer Part B Oral Oncology. 30(5). 290–295. 61 indexed citations
20.
Zheng, Xi, Yuan Fang, Li–Fu Hu, et al.. (1994). Effect of B‐lymphocyte‐ and NPC‐derived EBV‐1 gene expression on in vitro growth and differentiation of human epithelial cells. International Journal of Cancer. 57(5). 747–753. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiyuki Horikawa Breakdown of academic impact, for papers by Qiuliang Wu Breakdown of academic impact, for papers by Nobuyuki Bandoh Breakdown of academic impact, for papers by Shuhei Sakakibara Breakdown of academic impact, for papers by R.H. Hruban Breakdown of academic impact, for papers by Brian Cao Breakdown of academic impact, for papers by Boris Kubuschok Breakdown of academic impact, for papers by Adel K. El‐Naggar Breakdown of academic impact, for papers by Stephen M. Thirdborough Breakdown of academic impact, for papers by Andre L. Reed
Rankless by CCL
2026